MAI Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

MAI Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-628	Closed	-$54.4K	–	3334
2026 Q1	$54.4K	Hold	628	–	–	﹤0.01%	2174
2025 Q4	$53.2K	Hold	628	–	–	﹤0.01%	1978
2025 Q3	$45.5K	Sell	628 -232	-27%	-$16K	﹤0.01%	1984
2025 Q2	$56.4K	Buy	860 +1	+0.1%	+$65	﹤0.01%	1785
2025 Q1	$60.6K	Sell	859 -69	-7%	-$4.79K	﹤0.01%	1653
2024 Q4	$61K	Buy	+928	New	+$63.9K	﹤0.01%	1666

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

MAI Capital Management's IHE Position: Q2 2026 in Review

MAI Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 628 shares — an estimated $54.4K sold.

MAI Capital Management first reported a position in IHE in Q4 2024 and held it in 6 quarters. The position peaked at $61K in Q4 2024. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

MAI Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 628 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $54.4K.
MAI Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and held it in 6 quarters.
MAI Capital Management's iShares US Pharmaceuticals ETF position peaked at $61K in Q4 2024.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.